Photo taken from Antonio Passaro/X
Apr 15, 2024, 01:09
Antonio Passaro: Our editorial on the groundbreaking ALINA trial
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on X/Twitter:
“Just published in NEJM our editorial on the groundbreaking ALINA trial, evaluating the role of adjuvant alectinib in patients with resected NSCLC carrying ALK rearrangements. A major advance for our patients!”
Source: Antonio Passaro/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 18, 2025, 00:00
Jan 17, 2025, 23:55
Jan 17, 2025, 23:47
Jan 17, 2025, 23:44
Jan 17, 2025, 23:00